{"title":"Exploring the anti-diabetic potential of Ulva lactuca flavonoids in a Drosophila model","authors":"Sotubdhi Sharma , Asif Mahmud , Md Amjad Patwary , Mantasha Mahmud Hia , Sobnom Mustari Shukti , Nusrat Jahan Tisha , Zobada Kanak Khan , Md Faruque Miah","doi":"10.1016/j.obmed.2025.100616","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>The study aimed to evaluate the anti-diabetic potential of <em>Ulva lactuca</em> crude flavonoids by assessing their effects on external morphology and hemolymph glucose concentrations in <em>Drosophila melanogaster</em> under various dietary conditions, including a high-sugar diet.</div></div><div><h3>Methods</h3><div>Four dietary conditions were tested in <em>D</em>. <em>melanogaster</em> to assess the effects of <em>U. lactuca</em> crude flavonoids: control diet, high-sugar diet, high-sugar with standard diet, and diets with flavonoid concentrations (0.1M, 0.2M, 0.3M). External morphology and hemolymph glucose concentrations were evaluated.</div></div><div><h3>Results</h3><div>Hemolymph glucose concentrations were found 0.045 mg/mL in the high-sugar group and 0.054 mg/mL in the sugar-with-standard diet group, compared to 0.016 mg/mL in control flies. Flavonoid treatments reduced glucose levels in a dose-dependent manner, with 0.1M, 0.2M, and 0.3M flavonoid concentrations lowering glucose to 0.038 mg/mL, 0.035 mg/mL, and 0.017 mg/mL, respectively. The highest concentration (0.3M) nearly restored glucose levels to those of the control, along with a significant decrease in both abdominal width (0.87 ± 0.03 mm) and body weight (1.27 ± 0.04 mg).</div></div><div><h3>Conclusion</h3><div><em>U. lactuca</em> flavonoids effectively reduced glucose levels and mitigated obesity in sugar-treated <em>D. melanogaster</em>, suggesting their potential as safe dietary interventions for metabolic disorders like diabetes.</div></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":"55 ","pages":"Article 100616"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451847625000363","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
The study aimed to evaluate the anti-diabetic potential of Ulva lactuca crude flavonoids by assessing their effects on external morphology and hemolymph glucose concentrations in Drosophila melanogaster under various dietary conditions, including a high-sugar diet.
Methods
Four dietary conditions were tested in D. melanogaster to assess the effects of U. lactuca crude flavonoids: control diet, high-sugar diet, high-sugar with standard diet, and diets with flavonoid concentrations (0.1M, 0.2M, 0.3M). External morphology and hemolymph glucose concentrations were evaluated.
Results
Hemolymph glucose concentrations were found 0.045 mg/mL in the high-sugar group and 0.054 mg/mL in the sugar-with-standard diet group, compared to 0.016 mg/mL in control flies. Flavonoid treatments reduced glucose levels in a dose-dependent manner, with 0.1M, 0.2M, and 0.3M flavonoid concentrations lowering glucose to 0.038 mg/mL, 0.035 mg/mL, and 0.017 mg/mL, respectively. The highest concentration (0.3M) nearly restored glucose levels to those of the control, along with a significant decrease in both abdominal width (0.87 ± 0.03 mm) and body weight (1.27 ± 0.04 mg).
Conclusion
U. lactuca flavonoids effectively reduced glucose levels and mitigated obesity in sugar-treated D. melanogaster, suggesting their potential as safe dietary interventions for metabolic disorders like diabetes.
Obesity MedicineMedicine-Public Health, Environmental and Occupational Health
CiteScore
5.50
自引率
0.00%
发文量
74
审稿时长
40 days
期刊介绍:
The official journal of the Shanghai Diabetes Institute Obesity is a disease of increasing global prevalence with serious effects on both the individual and society. Obesity Medicine focusses on health and disease, relating to the very broad spectrum of research in and impacting on humans. It is an interdisciplinary journal that addresses mechanisms of disease, epidemiology and co-morbidities. Obesity Medicine encompasses medical, societal, socioeconomic as well as preventive aspects of obesity and is aimed at researchers, practitioners and educators alike.